TY - JOUR
T1 - CD4+ T cells are essential for the development of destructive thyroiditis induced by anti–PD-1 antibody in thyroglobulin-immunized mice
AU - Yasuda, Yoshinori
AU - Iwama, Shintaro
AU - Sugiyama, Daisuke
AU - Okuji, Takayuki
AU - Kobayashi, Tomoko
AU - Ito, Masaaki
AU - Okada, Norio
AU - Enomoto, Atsushi
AU - Ito, Sachiko
AU - Yan, Yue
AU - Sugiyama, Mariko
AU - Onoue, Takeshi
AU - Tsunekawa, Taku
AU - Ito, Yoshihiro
AU - Takagi, Hiroshi
AU - Hagiwara, Daisuke
AU - Goto, Motomitsu
AU - Suga, Hidetaka
AU - Banno, Ryoichi
AU - Takahashi, Masahide
AU - Nishikawa, Hiroyoshi
AU - Arima, Hiroshi
N1 - Publisher Copyright:
Copyright © 2021 The Authors, some rights reserved;
PY - 2021/5/12
Y1 - 2021/5/12
N2 - Immune-related adverse events induced by anti–programmed cell death–1 antibodies (PD-1-Ab), including destructive thyroiditis (thyroid-irAE), are thought to be caused by activated T cells. However, the T cell subsets that are directly responsible for damaging self-organs remain unclear. To clarify which T cell subsets are involved in the development of thyroid-irAE, a mouse model of thyroid-irAE was analyzed. PD-1-Ab administration 2.5 months after immunization with thyroglobulin caused destructive thyroiditis. Thyroiditis was completely prevented by previous depletion of CD4+ T cells and partially prevented by depleting CD8+ T cells. The frequencies of central and effector memory CD4+ T cell subsets and the secretion of interferon-y after stimulation with thyroglobulin were increased in the cervical lymph nodes of mice with thyroid-irAE compared with controls. Histopathological analysis revealed infiltration of CD4+ T cells expressing granzyme B in thyroid glands and major histocompatibility complex class II expression on thyrocytes in mice with thyroid-irAE. Adoptive transfer of CD4+ T cells from cervical lymph nodes in mice with thyroid-irAE caused destruction of thyroid follicular architecture in the irradiated recipient mice. Flow cytometric analyses showed that the frequencies of central and effector memory CD4+ T cells expressing the cytotoxic marker CD27 were higher in peripheral blood mononuclear cells collected from patients with thyroid-irAE induced by PD-1-Ab versus those without. These data suggest a critical role for cytotoxic memory CD4+ T cells activated by PD-1-Ab in the pathogenesis of thyroid-irAE.
AB - Immune-related adverse events induced by anti–programmed cell death–1 antibodies (PD-1-Ab), including destructive thyroiditis (thyroid-irAE), are thought to be caused by activated T cells. However, the T cell subsets that are directly responsible for damaging self-organs remain unclear. To clarify which T cell subsets are involved in the development of thyroid-irAE, a mouse model of thyroid-irAE was analyzed. PD-1-Ab administration 2.5 months after immunization with thyroglobulin caused destructive thyroiditis. Thyroiditis was completely prevented by previous depletion of CD4+ T cells and partially prevented by depleting CD8+ T cells. The frequencies of central and effector memory CD4+ T cell subsets and the secretion of interferon-y after stimulation with thyroglobulin were increased in the cervical lymph nodes of mice with thyroid-irAE compared with controls. Histopathological analysis revealed infiltration of CD4+ T cells expressing granzyme B in thyroid glands and major histocompatibility complex class II expression on thyrocytes in mice with thyroid-irAE. Adoptive transfer of CD4+ T cells from cervical lymph nodes in mice with thyroid-irAE caused destruction of thyroid follicular architecture in the irradiated recipient mice. Flow cytometric analyses showed that the frequencies of central and effector memory CD4+ T cells expressing the cytotoxic marker CD27 were higher in peripheral blood mononuclear cells collected from patients with thyroid-irAE induced by PD-1-Ab versus those without. These data suggest a critical role for cytotoxic memory CD4+ T cells activated by PD-1-Ab in the pathogenesis of thyroid-irAE.
UR - http://www.scopus.com/inward/record.url?scp=85105841606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105841606&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.abb7495
DO - 10.1126/scitranslmed.abb7495
M3 - Article
C2 - 33980577
AN - SCOPUS:85105841606
SN - 1946-6234
VL - 13
JO - Science Translational Medicine
JF - Science Translational Medicine
IS - 593
M1 - eabb7495
ER -